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Around one-fifth of patients with coronavirus disease 2019 (COVID-19) show evidence of 
acute myocardial injury. The precise etiology remains unclear and the observation that some 
patients do not show obstructive coronary artery disease (CAD) on coronary angiography has 
further complicated our understanding of the pathophysiology. 
Takotsubo syndrome (TTS) constitutes an acute heart failure syndrome that may represent a 
form of acute catecholaminergic myocardial stunning. TTS presents with the typical 




11 patients with COVID-19 who were diagnosed with TTS based on current criteria were 
included and compared to 57 patients with COVID-19 alone and 3,215 patients with TTS to 
elucidate features of COVID-19 patients who develop TTS and to infer the underlying 
pathology. Furthermore, we have stratified COVID-19 patients with myocardial injury into 2 
groups: those with wall motion abnormalities and those without.  
While COVID-19 disproportionately affected men (68.0%), most patients with COVID-
19+TTS were female (88.1%). Most COVID-19+TTS patients had either physical (72.7%) or 
emotional (18.2%) triggers, most likely from infection with the severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV-2). Patients with COVID-19+TTS also tended to be 
older (mean age 72.4 years) compared to patients with COVID-19 alone (mean age 58.5 
years) and TTS (mean age 67.8 years). Chest pain was more common among patients with 
TTS, irrespective of COVID-19, while dyspnea was most prevalent among COVID-19 
patients who develop TTS. Importantly, patients with COVID-19 who developed TTS had 
significantly worse outcomes in terms of rates of respiratory therapy or in-hospital death 
(70.0%) than traditional cases of TTS (18.6%).  
Troponin and brain natriuretic peptide (BNP) levels were typically elevated at the time of 
admission in COVID-19 patients with myocardial injury, suggesting that the systemic 
inflammatory response may be precipitating troponin release in these patients. In contrast, in 
patients with COVID-19 and TTS, troponin and BNP levels were generally low upon 
admission but increased during hospitalization. Left ventricular ejection fraction was most 
significantly reduced in patients COVID-19+TTS among all the groups we analyzed, which 
correlated with the highest peak BNP values.  
Some of these cases of COVID-19 associated myocardial injury had global wall motion 
impairment, which we postulate may actually be a form of TTS. Although TTS typically 
presents with regional wall motion abnormalities (e.g., apical ballooning), a ‘globally’ 
reduced form has also been observed.1 It is conceivable that the cytokine storm and 
catecholamine surge in patients with COVID-19 may cause a ‘global’ form of TTS in which 
the basal myocardium is not able to compensate, leading to global hypokinesia (Figure 1). 
Patients with TTS also generally show localized edema in the region of the wall motion 
abnormality on CMR. Meanwhile, a marked biventricular pattern of myocardial edema has 
been reported in a case of COVID-19-associated myocardial injury.2 We also observed a 
COVID-19 patient with TTS who showed marked edema in the region of the wall motion 
abnormality on CMR in addition to global edema (Figure 1). Indeed, as both TTS and 
COVID-19 can trigger microcirculatory dysfunction,3 it is possible they could act jointly 
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resulting in significant cardiac complications. In particular, the cytokine storm that occurs in 
COVID-19 may work in concert with the exaggerated sympathetic stimulation of TTS to 
activate similar (albeit currently unknown) pathways, resulting in severe microcirculatory 
dysfunction, global/regional myocardial edema, and decompensated acute heart failure. 
Of note, we observed contraction band necrosis with mononuclear infiltration in four of six 
patients who died due to COVID-19 and underwent autopsy (Figure 1). In comparison to 
coagulation necrosis in myocardial ischemia, contraction band necrosis can be seen as a result 
of the biopsy procedure or reflects catecholamine toxicity and sympathetic hyperactivity.4 
Indeed, the presence of contraction band necrosis and mononuclear infiltration has been 
reported previously in TTS,5 potentially reflecting sympathetic overdrive. Contraction bands 
in combination with mononuclear infiltration, argue against artifactual changes and is 
indicative of the acute phase of severe left ventricular dysfunction. Therefore, an earlier 
biopsy may reveal the true incidence of contraction band necrosis in cases of COVID-19 
myocardial injury with impaired wall motion abnormalities and normal coronary arteries. 
In summary, the severe inflammatory response that occurs in COVID-19 may work in concert 
with the exaggerated sympathetic stimulation of TTS to activate similar pathways, resulting in 
severe microcirculatory dysfunction, global/regional myocardial edema, and decompensated 
acute heart failure. We hypothesize the coronary microcirculatory disturbances resulting from 
the combination of COVID-19+TTS could trigger a sudden calcium influx, culminating in 
contraction band necrosis. Therefore, patients with a dual diagnosis of TTS and COVID are at 
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Electrocardiography (ECG; top row), left ventriculography (second row), and cardiac 
magnetic resonance images (CMR; third row) from patients with TTS, COVID-19, and 
COVID-19+TTS. Coronary angiography showed unobstructed coronary arteries in all three 
patients. The CMR images display the 2-chamber cine frame; the basal, mid-ventricular, and 
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apical T2 maps, and the T2 bulls eye plot. In-hospital outcomes (including death or 
ventilation) are also summarised (bottom left). Routine hematoxylin and eosin (H&E) stained 
section of the posterior myocardial wall from a COVID-19+TTS patient (autopsy heart 
specimen; bottom right). 
First column: TTS patients show deep negative T-waves and prolonged QTc time on ECG. 
Left ventriculography shows classical apical ballooning with compensatory hypercontractility 
of the basal segments. CMR with edema sensitive T2-mapping showed normal T2 values in 
the basal segments and edema of the mid-ventricular and apical segments (T2 z-score mid-
ventricular and apical: 4 and 8). 
Second column: COVID-19 patient with ST-segment elevation in I, aVL, V5, and V6, with 
normal QTc time on ECG. Left ventriculography shows mildly-reduced left ventricular 
ejection fraction with infero- and antero- lateral basal hypokinesia. CMR demonstrates 
diffusely elevated T2 values that are accentuated in the hypokinetic segments (infero- lateral 
basal, T2 z-score: 5). 
Third column: COVID-19 TTS patients show significant ST-elevations in the septal and 
anterior chest leads on ECG after 3 weeks of intensive care treatment (including mechanical 
ventilation for acute respiratory distress syndrome). Left ventriculography shows rapid 
deterioration of left ventricular function with TTS wall motion pattern. Representative CMR 
shows excessively high T2 values over the entire myocardium, indicating global edema with 
peak values in the apical segments (T2 z-score: 9). The myocardial fibers show loss of cross-
striations and nuclei are not visible in most areas. Inset (higher magnification) shows several 
irregularly-shaped wavy contractions extending across the myocardial fibers (arrows). Some 
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